ABD’li Covid-19 vaccine developer Modern In the statement made today, it was stated that the vaccine started to be tested in children younger than 12 years old.
KidCOVE According to the study called, the vaccine will be tested on 6 thousand 750 children from 6 months to 11 years old.
THE AGE WILL BE REDUCED AS YOU GO
While it is announced that the ‘age reduction’ technique will be used in the study to be carried out in cooperation with the National Institutes of Health, vaccination trials will be made for younger children every day, depending on the success of the vaccination study, which will start with 11-year-old children.
LOW DOSE WORK WILL BE CARRIED OUT AT THE SAME TIME
While it is stated that the dose differences will be tested in the study, the researchers will first test the effectiveness of the vaccine by applying a very small dose of the vaccine and increasing the dose amount with each passing test.
Moderna stated that the trial will take place in the US and Canada, while the company reported that the trial on children aged 12-17 will be announced next spring.
The effectiveness rate of the Covid-19 vaccine called MRNA-1273, based on Moderna’s mRNA technology, was announced as 94.1 percent.